HLA-DRB1 rs3093017: Understanding Parkinson's Disease Associations
The rs3093017 variant is a genetic marker located within the HLA-DRB1 gene region. It has been identified in genome-wide association studies as having a statistical link to susceptibility for Parkinson's disease.
What each genotype means
Baseline Parkinson's risk
This genotype represents the baseline state for this genetic marker in the context of Parkinson's disease research. Current studies indicate that this specific variant is associated with susceptibility to the condition, though individual risk is influenced by many genetic and environmental factors. This information is for educational purposes and does not constitute a medical diagnosis.
This genotype is common in most global populations, though exact frequencies vary by ancestry.
Associated Parkinson's risk
Research has identified this genotype as a marker associated with a modified risk profile for Parkinson's disease. Because genetic associations are statistical in nature, carrying this genotype does not mean an individual will develop the condition. Please consult with a healthcare professional to discuss your overall health and any concerns regarding neurological wellness.
This heterozygous genotype is frequently observed across diverse ancestral groups.
Elevated Parkinson's risk
This genotype has been identified in genome-wide association studies as a marker linked to an increased susceptibility to Parkinson's disease. It is important to remember that complex diseases like Parkinson's are influenced by a combination of multiple genes and environmental factors. This finding is a statistical association and should not be interpreted as a diagnostic result.
This genotype is found at varying frequencies globally, appearing in a significant portion of the population.
What is the rs3093017 Variant?
The rs3093017 variant is a single nucleotide polymorphism (SNP) located in the human genome within the highly complex HLA (Human Leukocyte Antigen) region. SNPs are the most common type of genetic variation among people, representing a difference in a single DNA building block, or nucleotide. In the context of the HLA-DRB1 gene, this variant sits in a region responsible for regulating immune responses. Researchers track these specific markers to understand how variations in our genetic code might correlate with complex health conditions. Because this region is involved in how the body recognizes foreign substances, scientists are particularly interested in how variations here might influence chronic inflammatory or neurodegenerative processes. It is important to note that identifying a SNP like rs3093017 does not mean it directly causes a disease; rather, it serves as a statistical signal that helps researchers narrow down which parts of the genome may be involved in disease susceptibility.
The Role of the HLA-DRB1 Gene
The HLA-DRB1 gene is part of the major histocompatibility complex (MHC), a critical component of the human immune system. This gene provides instructions for making proteins that sit on the surface of cells and present pieces of proteins (peptides) to the immune system. By doing so, these proteins help the body distinguish between its own healthy cells and foreign invaders like viruses or bacteria. Because of its central role in immune surveillance, variations in HLA-DRB1 have been studied extensively in relation to autoimmune disorders and, more recently, neurodegenerative conditions. The complexity of this gene region makes it a focal point for research into how the immune system might inadvertently contribute to the damage of neurons in the brain. Understanding the function of HLA-DRB1 is essential for interpreting why certain genetic markers in this area are flagged in large-scale studies investigating the biological underpinnings of Parkinson's disease.
Research and Statistical Associations
Scientific research, including genome-wide association studies (GWAS), has identified rs3093017 as a marker associated with Parkinson's disease. These studies compare the genomes of thousands of individuals with and without the condition to find patterns that occur more frequently in the affected group. While the evidence linking the HLA region to Parkinson's is considered significant in the scientific community, the association is complex and likely involves multiple genetic and environmental factors. It is crucial to understand that a statistical association is not a diagnosis. Many people carry this variant without ever developing Parkinson's disease, and many people with Parkinson's do not carry this specific marker. The current evidence suggests that this variant is one piece of a much larger, intricate puzzle involving immune system regulation and neurodegeneration. Researchers continue to investigate how these genetic signals translate into biological changes in the brain, but the clinical utility of this specific SNP for individual risk prediction remains limited.
Interpreting Your Genetic Information
If you have received information about your genotype for rs3093017, it is important to view it through the lens of population-level statistics rather than individual health outcomes. Genetic testing for complex traits like Parkinson's disease is not a diagnostic tool, and the presence of a specific allele does not determine your future health. Because Parkinson's is a multifactorial condition influenced by a combination of genetics, lifestyle, and environmental exposures, no single SNP can provide a complete picture of risk. You cannot use this information to make medical decisions or predict a diagnosis. If you have concerns about your neurological health or family history, the most appropriate step is to consult with a healthcare professional or a genetic counselor. They can help you interpret your results in the context of your overall health and provide guidance based on established clinical standards, rather than relying on isolated genetic markers.
How common is this variant?
The rs3093017 variant is common in most global populations, with the A and G alleles appearing at varying frequencies depending on ancestral background.
Frequently asked questions
Does having the rs3093017 variant mean I will get Parkinson's disease?
No. This variant is only a statistical marker associated with a slightly altered risk in population studies. It is not a diagnostic test, and most people with this variant will never develop the condition.
Can I use this SNP to predict my risk of Parkinson's?
Currently, this SNP is not used for individual risk prediction in a clinical setting. Parkinson's disease is highly complex, and genetic markers like this provide only a very small fraction of the total information regarding an individual's health.
What should I do if I am worried about my genetic results?
If you are concerned about your genetic information or family history, you should speak with a doctor or a certified genetic counselor. They can provide context and help you understand what these results mean for your specific situation.
Is the HLA-DRB1 gene only related to Parkinson's?
No, the HLA-DRB1 gene is primarily known for its role in the immune system. It has been studied in relation to many different conditions, including various autoimmune diseases and inflammatory responses.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3093017?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HLA-DRB1
This variant is a well-established genetic risk factor for multiple sclerosis, specifically associated with the HLA-DRB1*15:01 allele.
This variant is a well-established marker in the HLA region significantly associated with susceptibility to rheumatoid arthritis and other immune-mediated conditions.
This variant is a lead signal in the HLA region associated with susceptibility to nodular sclerosis Hodgkin lymphoma.
Variant in the HLA-DRB1 region associated with inflammatory bowel disease (IBD) severity and clinical outcomes.
An intergenic/intronic HLA class II variant significantly associated with multiple allergic sensitization phenotypes including pollen and animal dander.
This SNP is linked to immune response regulation and autoimmune disease risk.